Nexus Investment Management ULC

Position in MRK — Merck & Co., Inc.

CIK 1476329 TORONTO, A6

Position in MRK

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$479,947

+$30,664 QoQ

Shares Held

3,735

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#2,729

of 3,769 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nexus Investment Management ULC holds $61,054,403 across 9 Drug Manufacturers - General names. MRK ranks #6 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	251,016	$31,713,361
2	PFE	Pfizer Inc	1,023,770	$24,652,381
3	JNJ	Johnson & Johnson	8,381	$2,128,522
4	LLY	ELI LILLY & Co	769	$922,361
5	ABBV	AbbVie Inc.	3,456	$869,667
6	MRK	Merck & Co., Inc. This page	3,735	$479,947
7	BIIB	Biogen Inc.	920	$198,775
8	BMY	Bristol Myers Squibb Co	953	$54,911

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$479,947	3,735	0.0%	Shares	Sole	2026-07-20
2026-03-31	$449,283	3,735	0.0%	Shares	Sole	2026-04-20
2025-12-31	$393,146	3,735	0.0%	Shares	Sole	2026-01-21
2025-09-30	$313,478	3,735	0.0%	Shares	Sole	2025-10-24
2025-06-30	$295,662	3,735	0.0%	Shares	Sole	2025-07-28
2025-03-31	$335,253	3,735	+42.3%	Shares	Sole	2025-04-07
2024-12-31	$261,135	2,625	0.0%	Shares	Sole	2025-01-15
2024-09-30	$298,095	2,625	0.0%	Shares	Sole	2024-10-15
2024-06-30	$324,975	2,625	0.0%	Shares	Sole	2024-07-23
2024-03-31	$346,368	2,625	0.0%	Shares	Sole	2024-04-10
2023-12-31	$286,177	2,625	0.0%	Shares	Sole	2024-01-19
2023-09-30	$270,243	2,625	0.0%	Shares	Sole	2023-10-11
2023-06-30	$302,898	2,625	0.0%	Shares	Sole	2023-07-07
2023-03-31	$279,273	2,625	0.0%	Shares	Sole	2023-04-04
2022-12-31	$291,243	2,625	—	Shares	Sole	2023-02-08
No filing history on record for this holder in this stock.